Novartis AG ADR [NVS] stock is trading at $130.5, up 2.59%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NVS shares have gain 4.39% over the last week, with a monthly amount glided 1.07%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Novartis AG ADR [NYSE: NVS] stock has seen the most recent analyst activity on September 12, 2025, when Goldman downgraded its rating to a Sell but kept the price target unchanged to $118 for it. Previously, Morgan Stanley upgraded its rating to Equal-Weight on August 08, 2025, and kept the price target unchanged to $123. On February 13, 2025, downgrade downgraded it’s rating to Neutral. Morgan Stanley started tracking the stock assigning a Underweight rating. Deutsche Bank upgraded its rating to a Buy. HSBC Securities downgraded its rating to Reduce for this stock on December 04, 2024. In a note dated September 11, 2024, BofA Securities downgraded a Neutral rating on this stock and revised its target price from $135 to $130.
Novartis AG ADR [NVS] stock has fluctuated between $96.06 and $133.55 over the past year. Currently, Wall Street analysts expect the stock to reach $126 within the next 12 months. Novartis AG ADR [NYSE: NVS] shares were valued at $130.5 at the most recent close of the market. An investor can expect a potential drop of -3.45% based on the average NVS price forecast.
Analyzing the NVS fundamentals
Novartis AG ADR [NYSE:NVS] reported sales of 54.46B for the trailing twelve months, which represents a growth of 7.04%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at 0.3%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.25%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.33 and Total Capital is 0.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.78.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 129.25 points at the first support level, and at 128.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 131.22, and for the 2nd resistance point, it is at 131.94.
Ratios To Look Out For
For context, Novartis AG ADR’s Current Ratio is 0.88. Also, the Quick Ratio is 0.68, while the Cash Ratio stands at 0.21. Considering the valuation of this stock, the price to sales ratio is 4.55, the price to book ratio is 5.65 and price to earnings (TTM) ratio is 17.79.
Transactions by insiders
Recent insider trading involved Marshall Fiona, Officer, that happened on May 23 ’25 when 15000.0 shares were purchased. Officer, Kowalski Robert William completed a deal on Apr 30 ’25 to buy 1212.0 shares.
